Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer

BACKGROUND: There has been remarkable progress in systemic chemotherapy for metastatic colorectal cancer due to the widespread use of irinotecan, oxaliplatin, anti-vascular endothelial growth factor antibody, and anti-epidermal growth factor receptor antibody. It is important to continue treatment w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Kotaka, Masahito, Ikeda, Fusao, Tsujie, Masaki, Yoshioka, Shinichi, Nakamoto, Yoshihiko, Ishii, Takaaki, Kyogoku, Takahisa, Kato, Takeshi, Tsuji, Akihito, Kobayashi, Michiya
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4944910/
https://ncbi.nlm.nih.gov/pubmed/27468238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S104140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados